Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Editorial

    Editorial

    wadmin1By wadmin1January 1, 2021Updated:August 5, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Ian Edwin Cock1,2,*
    1Environmental Futures Research Institute, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    2School of Natural Sciences, Nathan Campus, Griffith University, Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.

    Pharmacognosy Communications,2021,11,1,1.
    DOI:10.5530/pc.2021.1.1
    Published: January 2021
    Type: Editorial

    ABSTRACT

    Dear Readers and Authors,

    I am pleased to bring you Volume 11, Issue 1 of Pharmacognosy Communications. In this issue we present new research reports examining the pharmacognosy of several important medicinal plants including the antibacterial activity of Astrotrichia latifolia Benth., Brassica oleracea L. (kale) and Arthrospira spp. (spirulina) extracts. We also include a number of reviews of medicinal plants and their constituents. In particular, this issue presents reviews on the phytochemistry and medicinal properties of leek (Allium ampeloprasum), Schisandra chinensis, lychee (Lintci chinensis), Chinese star anise, Asafoetida (the dried latex of Ferula spp.), as well as on the isolated compounds huperzinea (isolated from club moss) and galactomannans and diosgenin isolated from fenugreek. Furthermore, a timely invited review on the potential of pharmacognostic preparations in combatting the current COVID-19 pandemic has been included to focus researchers attention on previous studies in this field and to highlight future areas of research. Notably, a short discussion of a recent publication that highlights the potential of pomegranate peel extracts against SARS-CoV-2 (the viral cause of COVID-19) is also included in the Janus Corner. Read more…

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up